Akoya Biosciences, Inc. (AKYA) Financials

$3.02

north_east
$0.2 (7.09%)
Day's range
$2.76
Day's range
$3.05

AKYA Income statement / Annual

Last year (2023), Akoya Biosciences, Inc.'s total revenue was $96.63 M, an increase of 29.09% from the previous year. In 2023, Akoya Biosciences, Inc.'s net income was -$63.32 M. See Akoya Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $96.63 M $74.86 M $54.92 M $42.44 M $42.24 M
Cost of Revenue $40.33 M $31.47 M $20.70 M $16.54 M $17.57 M
Gross Profit $56.31 M $43.39 M $34.22 M $25.91 M $24.66 M
Gross Profit Ratio 0.58 0.58 0.62 0.61 0.58
Research and Development Expenses $21.89 M $23.21 M $15.70 M $9.60 M $8.76 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $25.45 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $900,000.00
Selling, General & Administrative Expenses $82.38 M $79.65 M $51.02 M $23.98 M $26.35 M
Other Expenses $9.70 M $6.73 M $4.73 M $3.82 M $3.06 M
Operating Expenses $113.97 M $109.60 M $71.44 M $37.40 M $38.17 M
Cost And Expenses $154.30 M $141.07 M $92.14 M $53.94 M $55.74 M
Interest Income $3.49 M $777,000.00 $91,000.00 $2.72 M $1.88 M
Interest Expense $8.76 M $4.55 M $3.12 M $2.72 M $1.88 M
Depreciation & Amortization $8.89 M $7.15 M $4.79 M $3.82 M $3.06 M
EBITDA -$45.63 M -$58.82 M -$35.17 M -$10.13 M -$9.62 M
EBITDA Ratio -0.47 -0.79 -0.6 -0.18 -0.26
Operating Income Ratio -0.6 -0.88 -0.68 -0.27 -0.32
Total Other Income/Expenses Net -$5.62 M -$4.41 M -$3.78 M -$4.65 M -$2.25 M
Income Before Tax -$63.28 M -$70.52 M -$43.08 M -$16.66 M -$14.56 M
Income Before Tax Ratio -0.65 -0.94 -0.78 -0.39 -0.34
Income Tax Expense $40,000.00 $123,000.00 -$140,000.00 $42,000.00 $194,000.00
Net Income -$63.32 M -$70.64 M -$42.94 M -$16.71 M -$14.75 M
Net Income Ratio -0.66 -0.94 -0.78 -0.39 -0.35
EPS -1.43 -1.87 -1.15 -0.45 -0.4
EPS Diluted -1.43 -1.87 -1.15 -0.45 -0.4
Weighted Average Shares Out $44.43 M $37.75 M $37.42 M $37.11 M $37.11 M
Weighted Average Shares Out Diluted $44.43 M $37.75 M $37.42 M $37.11 M $37.11 M
Link